Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia

Wael El-Rifai, E. Elonen, M. Larramendy, T. Ruutu, S. Knuutila

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Comparative genomic hybridization (CGH) was used to detect changes in DNA copy number in 25 cases of refractory acute myeloid leukemia (AML). CGH detected changes in DNA copy number in nine AML (36%). Losses (82%) were more frequent than gains (18%). No high-level amplifications were detected in any of the cases. Losses involved minimal overlapping regions at 5q14q32, 7q31.2q32 and 12p12. The most frequent gain was detected at 8q. CGH gave normal results in all cases with a normal karyotype or a translocation as the sole aberration. The absence of high-level DNA copy gains suggests that, in contrast to other malignancies, gene amplification is not an important mechanism for drug resistance in AML. In addition to 5q and 7q, known to be associated with disease refractoriness, 12p may be another region related to poor prognosis.

Original languageEnglish (US)
Pages (from-to)958-963
Number of pages6
JournalLeukemia
Volume11
Issue number7
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

DNA Copy Number Variations
Comparative Genomic Hybridization
Acute Myeloid Leukemia
Gene Amplification
Karyotype
Drug Resistance
DNA
Neoplasms

Keywords

  • 12p
  • 5q
  • 7q
  • CGH
  • Refractory AML

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

El-Rifai, W., Elonen, E., Larramendy, M., Ruutu, T., & Knuutila, S. (1997). Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia. Leukemia, 11(7), 958-963.

Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia. / El-Rifai, Wael; Elonen, E.; Larramendy, M.; Ruutu, T.; Knuutila, S.

In: Leukemia, Vol. 11, No. 7, 01.01.1997, p. 958-963.

Research output: Contribution to journalArticle

El-Rifai, W, Elonen, E, Larramendy, M, Ruutu, T & Knuutila, S 1997, 'Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia', Leukemia, vol. 11, no. 7, pp. 958-963.
El-Rifai W, Elonen E, Larramendy M, Ruutu T, Knuutila S. Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia. Leukemia. 1997 Jan 1;11(7):958-963.
El-Rifai, Wael ; Elonen, E. ; Larramendy, M. ; Ruutu, T. ; Knuutila, S. / Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia. In: Leukemia. 1997 ; Vol. 11, No. 7. pp. 958-963.
@article{c5a549e4c10a48ed9593f6c313f91782,
title = "Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia",
abstract = "Comparative genomic hybridization (CGH) was used to detect changes in DNA copy number in 25 cases of refractory acute myeloid leukemia (AML). CGH detected changes in DNA copy number in nine AML (36{\%}). Losses (82{\%}) were more frequent than gains (18{\%}). No high-level amplifications were detected in any of the cases. Losses involved minimal overlapping regions at 5q14q32, 7q31.2q32 and 12p12. The most frequent gain was detected at 8q. CGH gave normal results in all cases with a normal karyotype or a translocation as the sole aberration. The absence of high-level DNA copy gains suggests that, in contrast to other malignancies, gene amplification is not an important mechanism for drug resistance in AML. In addition to 5q and 7q, known to be associated with disease refractoriness, 12p may be another region related to poor prognosis.",
keywords = "12p, 5q, 7q, CGH, Refractory AML",
author = "Wael El-Rifai and E. Elonen and M. Larramendy and T. Ruutu and S. Knuutila",
year = "1997",
month = "1",
day = "1",
language = "English (US)",
volume = "11",
pages = "958--963",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia

AU - El-Rifai, Wael

AU - Elonen, E.

AU - Larramendy, M.

AU - Ruutu, T.

AU - Knuutila, S.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Comparative genomic hybridization (CGH) was used to detect changes in DNA copy number in 25 cases of refractory acute myeloid leukemia (AML). CGH detected changes in DNA copy number in nine AML (36%). Losses (82%) were more frequent than gains (18%). No high-level amplifications were detected in any of the cases. Losses involved minimal overlapping regions at 5q14q32, 7q31.2q32 and 12p12. The most frequent gain was detected at 8q. CGH gave normal results in all cases with a normal karyotype or a translocation as the sole aberration. The absence of high-level DNA copy gains suggests that, in contrast to other malignancies, gene amplification is not an important mechanism for drug resistance in AML. In addition to 5q and 7q, known to be associated with disease refractoriness, 12p may be another region related to poor prognosis.

AB - Comparative genomic hybridization (CGH) was used to detect changes in DNA copy number in 25 cases of refractory acute myeloid leukemia (AML). CGH detected changes in DNA copy number in nine AML (36%). Losses (82%) were more frequent than gains (18%). No high-level amplifications were detected in any of the cases. Losses involved minimal overlapping regions at 5q14q32, 7q31.2q32 and 12p12. The most frequent gain was detected at 8q. CGH gave normal results in all cases with a normal karyotype or a translocation as the sole aberration. The absence of high-level DNA copy gains suggests that, in contrast to other malignancies, gene amplification is not an important mechanism for drug resistance in AML. In addition to 5q and 7q, known to be associated with disease refractoriness, 12p may be another region related to poor prognosis.

KW - 12p

KW - 5q

KW - 7q

KW - CGH

KW - Refractory AML

UR - http://www.scopus.com/inward/record.url?scp=0030795838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030795838&partnerID=8YFLogxK

M3 - Article

C2 - 9204975

AN - SCOPUS:0030795838

VL - 11

SP - 958

EP - 963

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 7

ER -